Delivery Order SPE2DB25D3002-SPE2DB25FLQDD

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,464.05, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, with a completion date of July 1, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designations. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $2,018.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 sensors, a medical device used for diabetes management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,086.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexcom G7 sensors, a medical device for diabetes management. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $2,439.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. This is a firm fixed-price delivery order contract with a period of performance through December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,525.45, is for the delivery of DEXCOM G7 SENSORS, a medical device product. The contract has an ultimate completion date of January 21, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for a specific type of business. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $2,327.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $2,251.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract is a delivery order, with a firm fixed price, and has an ultimate completion date of November 14, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $2,009.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for glucose monitoring, with a completion date of December 30, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, valued at $1,023.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexcom G7 Sensors, a type of medical device used for glucose monitoring. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 4, 2024. It is not designated with any set-aside requirements,...
This federal contract award, valued at $4,956.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 13, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLQDD
    Delivery Order

This federal contract award, valued at $1,042.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, and has an ultimate completion date of February 27, 2025.

The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/28/25, 10:42 AM